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Abstract
In 2005, the first robust hepatitis C virus (HCV) infectious cell culture system was developed based on the HCV genotype 2a
JFH-1 molecular clone and the human-derived hepatoma cell line Huh7. Although much effort has been made to dissect
and expand the repertoire of JFH-1-derived clones, less attention has been given to the host cell despite the intriguing facts
that thus far only Huh7 cells have been found to be highly permissive for HCV infection and furthermore only a limited
number of Huh7 cell lines/stocks appear to be fully permissive. As such, we compiled a panel of Huh7 lines from disparate
sources and evaluated their permissiveness for HCV infection. We found that although Huh7 lines from different laboratories
do vary in morphology and cell growth, the majority (8 out of 9) were highly permissive for infection, as demonstrated by
robust HCV RNA and de novo infectious virion production following infection. While HCV RNA levels achieved in the 8
permissive cell lines were relatively equivalent, three Huh7 lines demonstrated higher infectious virion production
suggesting these cell lines more efficiently support post-replication event(s) in the viral life cycle. Consistent with previous
studies, the single Huh7 line found to be relatively resistant to infection demonstrated a block in HCV entry. These studies
not only suggest that the majority of Huh7 cell lines in different laboratories are in fact highly permissive for HCV infection,
but also identify phenotypically distinct Huh7 lines, which may facilitate studies investigating the cellular determinants of
HCV infection.
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Introduction
Worldwide, ,170 million individuals are infected with hepatitis
C virus (HCV), an enveloped positive-strand RNA virus that
infects and replicates in the hepatocytes of the liver. Although
acute infection is typically asymptomatic, ,80% of patients fail to
clear the virus resulting in a chronic infection associated with
significant liver disease, including cirrhosis and hepatocellular
carcinoma [1].
Since its discovery in 1989 [2], the viral life cycle and host-virus
interactions that determine infection outcome have been difficult
to study because experimental HCV cell culture infection systems
have been limited. Fortunately, in 2003 Wakita and colleagues
cloned a HCV consensus genotype 2a genome (JFH-1) from a
Japanese Fulminant Hepatitis patient [3], which was subsequently
found to produce infectious HCV in Huh7 cell cultures [4–6].
This breakthrough was the result of two culminating factors: (1)
identification of a HCV clone capable of replicating and
assembling infectious particles in cell culture and (2) discovery
that Huh7 cells are permissive for HCV infection. Surprisingly,
however, significant variability in HCV permissiveness was
observed among the original 3 Huh7 cell lines used to report
HCV infection in vitro leading some to conclude that permissive-
ness for HCV may be limited to only a few Huh7 lines [7]. To test
this hypothesis, we assembled a panel of Huh7 cell lines from
disparate sources and assessed their permissiveness for HCV
infection.
Here we show that although different Huh7 cell lines do vary in
morphology and growth, 8 of 9 tested were highly permissive for
HCV infection as demonstrated by robust HCV RNA and
infectious virion production. Thus, this study illustrates that
contrary to commonly held perception, HCV permissiveness does
not appear to be restricted to only a few Huh7 cell lines.
Furthermore, this effort has identified a panel of phenotypically
distinct HCV-permissive Huh7 lines, which should facilitate
studies investigating the cellular determinants of HCV infection.
Materials and Methods
Cells and viruses
Huh7-1 cells (also known as Huh7/scr cells [8,9]) and Huh7.5.1
cells were obtained from Dr. Chisari (The Scripps Research
Institute, La Jolla, CA) [6]. Huh7 cells designated Huh7-RRB were
purchased from the Japan Health Science Research Resources Bank
(JHSRRB, cat#JCRB0403). All other Huh7 cells were donated
without restrictions by researchers outside the HCV research field,
were blindly catalogued, and named Huh7-2 through Huh7-9; with
the exclusion of Huh7-5 to avoid confusion with existing Huh7.5
[6,10] and Huh7.5.1 cells [6]. These arbitrarily named and
subsequently characterized cell lines are available upon request.
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Eagle’s medium (DMEM) (Hyclone, Logan, UT) supplemented
with 10% fetal bovine serum (FBS) (Hyclone), 100 units/ml
penicillin, 100 mg/ml streptomycin, and 2 mM L-glutamine
(Gibco Invitrogen, Carlsbad, CA). Cells were initially cultured
for two consecutive weeks with Plasmocin (Invivogen, San Diego,
CA) at 25 mg/ml, as per the manufacturer’s instructions, to cure
all cell lines of possible mycoplasma contamination. Confirmation
of mycoplasma free cultures following treatment and throughout
the course of this study was determined using the MycoProbe
TM
Mycoplasma Detection Kit (R&D Systems, Minneapolis, MN), as
per the manufacturer’s instructions (data not shown).
The genotype 2a JFH-1 plasmid (pJFH-1) has been previously
described [5] and was kindly provided by Dr. Wakita (National
Institute of Infectious Diseases, Tokyo, Japan). JFH-1 cell culture-
propagated HCV (HCVcc) viral stocks were obtained by infection
of naı ¨ve Huh7-1 cells at a multiplicity of infection (MOI) of 0.01
focus forming units (FFU)/cell, using medium collected from
Huh7-1 cells on day 18 post transfection with in vitro transcribed
pJFH-1 RNA as previously described [6]. Although HCV similarly
collected at day 18 post transfection has been sequenced and
determined not to contain any detectable adaptive mutations [9],
we note that as with any propagated RNA virus, it is possible
viruses containing adaptive mutations may be present within the
HCV stock utilized.
Growth kinetics
To ensure that none of the Huh7 cell lines would reach
confluence during the 3 day period in which growth was
monitored, a confluence of ,40% was targeted by seeding
,5610
4 Huh7 cells in each well of a 12-well tissue culture plate
(Corning, Lowell, MA). At indicated times post seeding, medium
from triplicate wells was removed, cells were washed once with
0.5 ml of 1X phosphate buffered saline (PBS), and trypsinized for
4 minutes at room temperature. Cells were resuspended to a final
volume of 1 ml with complete DMEM and total cell numbers were
determined using a hemacytometer.
Viral propagation in different Huh7 cell lines
For each Huh7 cell line, 1.5610
5 cells were seeded in one T75
flask. Twenty four hours post seeding, medium was removed, cells
were rinsed once with 10 ml of 1X PBS and then inoculated with
JFH-1 HCVcc at an MOI of 0.01 FFU/cell in a total volume of
10 ml complete DMEM. Upon reaching confluence, cells were
split 1:3 until day 10 post-infection (p.i.). At indicated time points,
supernatant was collected and infectivity titers determined by
titration on naı ¨ve Huh7 cells.
Infectivity titration assay
Culture supernatants were serially diluted 10-fold and used to
infect duplicate 96-well Huh7 cultures. At 24 h p.i., cultures were
overlaid with complete DMEM containing a final concentration of
0.25% methylcellulose (Fluka BioChemika, Switzerland). Seventy-
two hours p.i., cells were fixed in 4% paraformaldehyde (Sigma,
St. Louis, MO), and immunohistochemically stained for HCV E2
using the human monoclonal anti-E2 antibody C1 [11] (a gift from
Dennis Burton, The Scripps Research Institute). Viral titers are
expressed as FFU/ml, determined by the average E2-positive foci
number detected at the highest HCV-positive dilution.
HCV infection kinetics
Parallel cultures were infected with JFH-1 HCVcc at an MOI of
0.01 FFU/cell. Infected cells were trypsinzed before reaching
confluence and re-plated at a 1:3 dilution to maintain active
growth. At indicated times p.i., medium was harvested from
triplicate wells for titration and cellular RNA was isolated for
reverse transcription followed by real-time quantitative PCR
analysis (RTqPCR).
RNA isolation and RTqPCR
Cellular RNA was isolated using an ABI PRISM
TM6100
Nucleic Acid PrepStation (Applied Biosystems). One mg of RNA
was used for cDNA synthesis using TaqMan reverse transcription
reagents (Applied Biosystems), followed by SYBRgreen RTqPCR
using an Applied Biosystems 7300 real-time thermocycler as
previously described [12]. HCV and GAPDH transcript levels
were determined relative to standard curves of serially diluted
JFH-1 or human GAPDH plasmids, respectively. Primers used are
listed in Table S1.
Pseudotyped retrovirus production and infections
Pseudotyped viruses were produced as previously described
[13]. Briefly, DNA encoding HCV or vesicular stomatitis virus
(VSV) glycoproteins were co-transfected with the Env-deficient
HIV vector carrying a luciferase reporter gene (pNL4-3-Luc-R
--
E
-) into 293T producer cells. Supernatants were collected 48 h
post transfection, filtered through a 0.45 mm-pore-size filter (BD
Biosciences), aliquoted, frozen and subsequently tittered using the
QuickTiter Lentivirus Titer Kit (Cell Biolabs, Inc., San Diego,
CA) according to the manufacturer’s instructions. Huh7 cells were
inoculated with equal amounts of pseudotyped virus for 6 h,
washed twice with 1X PBS, and at 72 h p.i. lysed in 20 ml of lysis
reagent to measure luciferase activity (Promega, Madison, WI)
using a FLUOstar Optima microplate reader (BMG Labtechnol-
ogies Inc, Durham, NC). For pseudotyped virus infections of
transiently transfected cells, Huh7 cells were first electroporated
(Biorad, Hercules, CA), as described [14], with plasmids
expressing human CD81, scavenger receptor class B member 1
(SR-B1), claudin-1 (CLDN1) and/or occludin (10 mg total plasmid
per transfection) 48 h prior to infection.
Cellular dsRNA-response assay
Huh7 cells were mock-treated, treated with 100 U/ml IFN-b
(PBL, New Brunswick, NJ), mock-transfected or transfected with
0.3 mg poly(I/C) (Sigma) or 100 ng pEGFP-N1 (Clontech,
Mountain View, CA) using Lipofectamine
TM2000 (Invitrogen).
Photographs were taken (Nikon Eclipse TE2000) 16 h post-
transfection and cellular RNA was isolated for RTqPCR analysis
of EGFP and IFN-stimulated genes (ISGs) (Primers listed in Table
S1). EGFP transcript levels were normalized to GAPDH and copy
numbers determined relative to a standard curve of serial dilutions
of pEGFP-N1. Relative expression of ISGs was determined using
the 2
2DDCT method [15], by normalizing to GAPDH expression
levels.
Results
Morphological examination and growth kinetics
Since being isolated in 1982 from a Japanese male with a well-
differentiated hepatocellular carcinoma [16], Huh7 cells have
become widely used for the study of liver-related diseases and were
fundamental to the development of the HCV infectious cell culture
system [4–6]. Although commonly available, initial data suggested
that Huh7 cells in distinct laboratories may differ substantially
with respect to their ability to support HCVcc infection with only a
minority supporting robust HCV infection [5,7]. To test this
hypothesis, we evaluated eight Huh7 lines obtained from disparate
HCV Infection of 8 Huh7 Lines
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as these cells have been shown to be highly permissive for HCVcc
infection [8,9].
Following a two month acclimation period of culturing under
identical conditions, we evaluated the morphology (Figure 1) and
growth kinetics (Figure 2) of each Huh7 line. Typical of
hepatocytes, all cells grew in islands, exhibited cuboidal epitheli-
al-like morphology with low nucleus-to-cytoplasm ratio, were
mono- and bi-nucleated, and contained multiple nucleoli and
cytoplasmic granules (Figure 1, insets). However, compared to one
another, differences were evident. The Huh7-6 cells grew more
tightly packed and formed multilayered islands morphologically
distinct from the other cell lines which formed monolayer islands.
Although all eight cell lines were hexagonal, the Huh7-1 and
Huh7-2 cells were generally larger and more flattened, while the
Huh7-8 cells exhibited the most uniform cuboidal shape.
To assess the growth rate of each Huh7 line, equal number of
cells were plated in 12-well plates at ,40% confluence and cell
numbers determined at indicated times (Figure 2). By 48 h post-
seeding, a difference in cell numbers was noted with distinct
growth rates evident by 72 h. Specifically, the Huh7-3, -4, -7 and -
9 cells had similar growth rates, while the growth rates of Huh7-1
and Huh7-2 cells were slower and Huh7-6 and Huh7-8 cells were
faster (Figure 2).
Notably, although Huh7 cells are hepatoma cells, they do retain
some hepatocyte characteristics such as expression of certain
hepatocyte-specific genes [17]. As such, we confirmed the
hepatocyte nature of all the cell lines by evaluating the levels of
three hepatocyte-specific transcripts (hepatocyte nuclear factor 4-
a, transthyretin, and a-1-antitrypsin) by real-time RTqPCR [18].
When compared to the Huh7-1 cells, no discernible difference in
gene expression was detected (data not shown) confirming all the
cell lines do share similar Huh7-like characteristics despite their
morphological and growth differences.
Propagation of HCV
We next evaluated the ability of each cell line to propagate high
titer HCVcc stocks. Based on previous studies, JFH-1 HCVcc
titers were expected to peak 7-9 days p.i. [6]. As such, on days 7, 8
and 9 p.i., medium from HCVcc-infected cultures was collected
and infectious virus levels titrated on the respective naı ¨ve Huh7
cells in which the virus was propagated. As expected, Huh7-1 cells
efficiently propagated HCVcc with viral titers equal to 9610
3,
1.0610
4 and 5.0610
4 FFU/ml on days 7, 8 and 9 p.i., respectively
while the Huh7.5.1 cells, which have been shown to propagate
HCVcc to higher titers [6], produced HCVcc titers of 2.0610
5,
2.5610
5 and 5.0610
5 FFU/ml on days 7, 8 and 9 p.i., respectively
(Figure 3A). Interestingly however, with the exception of the
Huh7-6 cells, the other Huh7 cells similarly produced HCVcc to
high titers, with titers greater than 5610
4 FFU/ml detectable as
early as day 7 p.i. and titers $1610
5 FFU/ml by day 9 p.i.
Notably, the Huh7-2, -3 and -9 cells supported virus production
similar to that of Huh7.5.1 cells, with maximal titers of 1.5610
5,
6.1610
5 and 4.2610
5 FFU/ml detectable on day 9 p.i.,
respectively.
To eliminate any differences that might be a consequence of
particular cell lines being more amendable to the focus-forming
assay employed, we additionally titered all supernatants on the
more routinely used Huh7-1 line [6]. However, no significant
difference between titer values was observed on the Huh7 line in
which the virus was generated (Figure 3A) or naı ¨ve Huh7-1 cells
(Figure 3B). The only exception was Huh7-6 cells as this cell line
does not support HCV infection sufficiently to be used for accurate
titration analysis.
HCV-mediated CPE
Although the degree and time of onset varied, all Huh7 lines
exhibited some cytopathic effect (CPE) during infection, which
included cessation of cell growth and accumulation of rounded and
floating cells, similar to what has been reported in other Huh7 cells
[9] (Figure 3C and Table 1). While minor CPE was observed in the
Huh7-1 (and the relatively non-permissive Huh7-6 cultures), more
profound CPE was apparent in the other six Huh7 lines (Figure 3C,
insets), with the most rapid CPE occurring in Huh7-3, -7 and -9
cultures as early as day 5 p.i. leading to impairment of cell growth.
Morphology of HCV foci
Interestingly, when titering infectious supernatants from the
above experiment (Figure 3A) on the various Huh7 lines, we
consistently noted that the phenotypeof the foci formed on each cell
line varied (Figure 4). The foci formed on Huh7-2, -3 and -9 cells
were consistently larger, while the foci formed on Huh7-4 and -8
cells were equivalent in size to that observed in the Huh7-1 cultures,
and the foci formed on Huh7-6 and -7 cells were noticeably smaller.
Importantly, the same foci phenotypes were seen in the different
Huh7 cells when a single HCVcc JFH-1 virus stock, propagated on
Huh7-1 cells, was titered on all 8 Huh7 cell lines (data not shown).
Likewise, no difference in foci size was observed when parallel
Huh7-1 monolayers were inoculated with virus derived from the
different Huh7 cells (data not shown). Hence, the differences in foci
morphology were related entirely to the cell line used for titering
and not to differences in the infecting virus stocks.
Kinetics of HCV infection
The difference in viral titers and size of HCV-positive foci
observed among the various Huh7 cell lines suggested that some
aspect of infection might be more efficient in certain Huh7 lines.
Hence, we performed a kinetic analysis of HCVcc infection.
Specifically, intracellular HCV RNA accumulation and release of
infectious virus was examined daily for 8 days (Figure 5) in all the
Huh7 lines as well as in Huh7.5.1 cells [6] and the original Huh7
cell line established by Nakabayshi et al. in 1982 [16], which were
purchased from the JHSRRB (designated here Huh7-RRB) and
cultured under similar conditions.
One day p.i., intracellular HCV RNA levels were similar among
the majority of Huh7 lines (1.67610
466.10610
3 copies/mg RNA)
exponentially increasing thereafter ,1,500-fold by day 6 p.i.,
reaching a steady-state of 2.11610
764.44610
6 copies/mg RNA
(Figure 5A and Table 1). Notably, HCV RNA expansion and
plateau level reached was comparable among most Huh7 lines;
however, HCV RNA copies in various cultures did vary up to one
log on any given day with the Huh7-3 cells trending toward ,5-
fold greater levels days 2–6 p.i. The only exception was the lower
level of HCV RNA produced in the Huh7-6 cells.
Virus production kinetics weredetermined by titering supernatants
on both the Huh7 cell line from which the supernatant was harvested
(Figure 5B) and Huh7-1 cells (Figure 5C). Unlike HCV RNA
expansion, a difference in the initial levels and subsequent rate of
virus production among the Huh7 cells was observed. Excluding
Huh7-6cells,Huh7-1cellsproducedtheleastinfectiousviruswiththe
slowest rate reaching maximal titers of 8610
4 FFU/ml by day 7 p.i.
(Figure 5B–C). Although virus production rate from the Huh7-4, -7 -
8, and -RRB cells closely paralleled that of the Huh7-1 cells, titers
were consistentlyhigher days 3-5p.i.in these lines (Figure 5B).On the
other hand, Huh7-2, -3 and -9 cells produced virus at significantly
faster rates and higher levels, similar to that achieved in Huh7.5.1
cells (Figure 5B–C) and consistent with the propagation experiment
above (Figure 3A–B and Figure 4). Notably, by day 2 p.i., titers of
,10
3 FFU/ml were detectable in the supernatant of these three
HCV Infection of 8 Huh7 Lines
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reached maximal titers of ,10
5 FFU/ml by day 5 p.i.; two days
beforethe other Huh7 lines(Figure 5B). Similar results were obtained
when supernatants were titered on Huh7-1 cells (Figure 5C).
To more directly monitor cell-to-cell viral spread in the Huh7
cell lines, we also monitored HCV-positive cells at different times
p.i. by immunofluorescence (Figure S1 and Supplementary
Materials and Methods S1). Immunofluorescence staining for the
HCV E2 glycoprotein indicated that in general, the percentage of
E2-positive cells among the infected Huh7 cultures increased from
,2% on day 2 to almost 100% by day 7 (Figure S1); however, the
rate of spread (on days 4 to 7 p.i.) differed among the individual
Huh7 cell lines, with the Huh7-2, -3 and -9 cells exhibiting
accelerated spread kinetics. The percentage of E2-positive Huh7-
2, -3 and -9 cells by day 5 p.i. was ,90%, 95% and 85%,
respectively, while in parallel less then 30% of the Huh7-1, -4, -7
and -8 cells and less than 2% of the Huh7-6 cells were E2 positive.
This accelerated spread likely explains the faster rate of infectious
virus production observed from these three cell lines (Figure 5B–
C). Overall these results show that not only were the majority of
these randomly acquired Huh7 lines highly permissive for HCVcc,
but that permissiveness is a phenotype derived from the original
Huh7 cells maintained by the JHSRRB, as the Huh7-RRB cells
were equally permissive for HCVcc. Additionally, the data also
indicate that the HCVcc-permissive Huh7 lines within this panel
support varying levels of infectious progeny virus production.
Huh7-6 cells are entry deficient
To further characterize the Huh7 lines, including the refractory
phenotype of the Huh7-6 cells, we tested the ability of the cells to
support HCV pseudoparticle (HCVpp) entry and subgenomic
JFH-1 (sgJFH-1) replicon replication, as these assays independent-
Figure 1. Morphological analysis of Huh7 cell lines. Huh7 cells were plated at 5610
4 cells/well in a 12-well plate and photographed 2 days
after plating (magnification,6100; inset6400).
doi:10.1371/journal.pone.0006561.g001
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infected with pseudotyped lentiviruses bearing HCV E1 and E2 of
genotypes 2a or 1a (JFHpp and H77pp, respectively) or VSV G
glycoprotein (VSVGpp). All cell lines were highly and equally
permissive for VSVGpp infection; however, Huh7-4, -7 and -8
cells showed a 50–60% reduction in HCVpp entry, while Huh7-6
cells were 90% less permissive as compared to Huh7-1 cells
(Figure 6A); suggesting HCV entry is significantly impaired in
Huh7-6 cells. In contrast, when entry was bypassed, we detected
no difference in sgJFH-1 colony formation efficiency among the
different Huh7 lines (Figure S2 and Supplementary Materials and
Methods). Taken together, these observations indicate that a
defect in HCV entry likely explains the relatively non-permissive
nature of the Huh7-6 cells. Interestingly, reduced levels of HCV
entry in the Huh7-4, -7 and Huh7-8 cells may also explain the
lower level of early virus production (Figure 5B) observed with
these three HCVcc-permissive Huh7 cell lines.
Cell surface expression of HCV receptors
To functionally assess if reduced surface expression of one of the
putative cellular HCV receptors might be responsible for the low
HCVcc and HCVpp infectivity of the Huh7-6 cells, flow cytometric
analysis of CD81, low density lipoprotein-receptor (LDL-R) and
SR-B1 was performed (Figure S3 and Supplementary Materials and
Methods). Interestingly, while most of the Huh7 cell lines expressed
similar and uniformly high levels of CD81 on their cell surface, a bi-
modal CD81 expression profile was observed for Huh7-4 and
Huh7-8 cells (Figure S3A), similar to what was reported by
Koutsoudakis et al. for the relatively non-permissive Huh7-Lunet
cells [19]. Surface level expression of LDL-R and SR-B1 did not
vary among the Huh7 cell lines except for the Huh7-6 cells, which
had undetectable levels of SR-B1 (Figure S3B–C).
In light of these results, we transiently transfected Huh7-4 and -
8 cells as well as Huh7-6 cells with vectors expressing human
CD81 or SR-B1, respectively, and reassessed their permissiveness
for HCVpp infection 48 h post-transfection. As shown in
Figure 6B, expression of CD81 in trans significantly improved
HCVpp permissiveness to the Huh7-4 and -8 cells; however, SR-
B1 complementation did not rescue Huh7-6 cells (Figure 6C).
Likewise, permissiveness to HCVpp could not be conferred to the
Huh7-6 cell by expression of a panel of known HCV receptors,
alone or in combination, suggesting that Huh7-6 cells may be
defective in another currently unidentified HCV entry determi-
nant (Figure 6C).
Responsiveness of the dsRNA-signaling pathway in Huh7
cell lines
Finally, because abrogation of the cellular RIG-I/interferon
regulatory factor 3 (IRF-3) pathway can confer an advantage to
HCVcc in vitro (e.g. the Huh-7.5 cells [20]), we evaluated the
response of each Huh7 line to double-stranded RNA (dsRNA), an
inducer of this pathway [21,22]. Specifically, we transfected each
Huh7 line with 300 ng poly(I:C) and evaluated representative
IFN-inducible gene (ISG) transcript levels (ISG15, MxA and
ISG56) by RTqPCR. As a positive control for ISG induction,
separate cultures were treated with 100 U/ml IFN-b. To confirm
equivalent transfection efficiency, cells were additionally transfect-
ed with 100 ng pEGFP-N1 and EGFP protein and mRNA was
evaluated 16 h post-transfection. Importantly, no significant
differences in EGFP protein or mRNA levels were observed
among the Huh7 cell lines following transfection (Figure 7A) and
all eight lines responded to IFN-b treatment (Figure 7B).
The level of poly(I:C)-induced ISG expression, however, did
vary among the cell lines. Specifically, poly(I:C)-induced ISG up-
regulation was $10-fold in the Huh7-1, -3 and -7 cells, while the
Huh7-2, -6, and -9 cells exhibited #5-fold induction compared to
mock-transfected controls (Figure 7B). Thus, it is possible that
lower dsRNA responsiveness may in part explain the enhanced
HCVcc production in Huh7-2 and Huh7-9 cultures. Notably
however, the higher dsRNA-induced ISG expression observed in
the Huh7-3 cells did not seem to limit its capacity to support HCV
infection leading us to conclude that dsRNA-responsiveness must
not be the universal factor responsible for the differences in
infectious HCVcc production observed among these Huh7 cell
lines, as suggested for the Huh7.5 cells [20].
Discussion
In this study we characterized eight Huh7 cell lines at the level
of growth, morphology, and HCVcc permissiveness. As summa-
rized in Table 1, we show that in general all these Huh7 cells as
well as the original Huh7 cells preserved at JHSRRB are
inherently permissive for HCVcc infection; however, specific
differences were evident.
Phenotypic drift of continuous cell lines
Cell lines kept in culture can functionally evolve over time to no
longer represent the original cell line (reviewed in [23]). Since their
isolation in 1982 [16], this phenomena appears to have occurred
with some Huh7 cell lines. For example, Wakita and colleagues
found their Huh7 cell line to be relatively non-permissive [5] and
determined this was because most of the cells were CD81-negative
[24]. Notably, the one Huh7 cell line we found to be relatively non-
permissive, the Huh7-6 cell line, has also down-regulated an
essential HCV receptor, SR-B1, and perhaps another yet
unidentified entry factor. As a whole, however, the majority of the
Huh7 lines analyzed here maintained their inherent permissiveness
Figure 2. Growth kinetics of Huh7 cell lines. Cells were seeded at
5610
4 cells/well in a 12-well plate. At indicated times post-seeding,
cells were trypsinized and counted. Results are graphed as mean6sem
of triplicates.
doi:10.1371/journal.pone.0006561.g002
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general morphology were apparent (Figure 1 and Figure 2).
Permissiveness of Huh7 cell lines for HCVcc and HCVpp
infection
Considering the phenotypic differences observed among the
eight Huh7 cell lines collected for this study and based on previous
reports demonstrating low HCVcc infection efficiency in various
Huh7 cell lines [19,24], we were surprised that 7 of the 8 Huh7
lines tested efficiently propagated HCVcc (Figure 3A–B). In fact,
the level of de novo viral production for three of the cell lines (i.e.
Huh7-2, -3 and -9) was equal to that achieved by the ‘‘adapted’’
cell line, Huh7.5.1 [6] (Figure 3A).
(i) Differences in HCVcc foci formation. HCV-positive
foci size varied among the different Huh7 cell lines with larger foci
apparent in the Huh7-2, -3 and -9 cell lines (Figure 4), all three of
which propagated HCVcc to titers greater than that of the other
Huh7 cell lines (Fig. 3). More rapid cell division during the 3 day
assay does not appear to explain the increased foci size, since the
Huh7-2 cells demonstrated one of the slowest proliferation rates.
Hence, the size of the foci observed is more likely related to
differences in the rate of de novo viral production and/or spread.
(ii) Comparable HCVcc RNA amplification. Despite the
obvious difference in foci size, HCV RNA exponentially expanded
with similar kinetics and eventually reached comparable plateau
levels (,2.3610
7 HCV copies/mg RNA) in the different infected
Huh7 cell cultures, with the exception of the Huh7-6 cells which
consistently supported lower levels of HCV infection (Figure 5A and
Table 1). Similar RNA plateau levels were also reached in the Huh-
7.5.1 cells (Figure 5A). One possible explanation for the observed
plateau may be that Huh7 cells only have the capacity to support a
given level (,1.0610
7 copies/mg RNA) of HCV RNA replication
and this phenotype is maintained among the different cell lines.
Alternatively,themaximumRNAlevelobtained maybedetermined
by inherent life cycle regulatory strategies encoded by the virus.
(iii) Differences in infectious HCVcc production. Al-
though little variability was observed in HCV RNA levels in the
different Huh7 cultures, a higher degree of divergence was observed
in infectious virion production (Figure 5B–C). While, the Huh7-1, -
4, -7, -8 and -RRB cells demonstrated comparable levels, the Huh7-
2, -3 and -9 cells secreted infectious HCVcc sooner and to higher
titers, similar to that observed in Huh7.5.1 cells (Figure 5B–C).
Hence, it will be interesting to determine the mechanism(s) that
mediate what appears to be more efficient de novo virus production
in the Huh7-2, -3 and -9 cells (e.g. packaging, maturation and/or
Figure 3. Propagation of infectious HCV. Cells were infected with JFH-1 HCVcc at an MOI of 0.01 FFU/cell and supernatant harvested on days 7
(grey bars), 8 (black bars) and 9 (white bars) p.i. Infectivity titers were determined on (A) the Huh7 cells from which the virus was derived and (B)
Huh7-1 cells. Data represents three independent experiments. (C) HCV-induced CPE in Huh7 cells 8 days p.i. (magnification,6100; inset, 6400).
doi:10.1371/journal.pone.0006561.g003
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involved in these processes. Of note, viral entry-independent
assessment of early post-entry events (e.g. translation and RNA
replication) can be performed by transfecting in vitro transcribed
infectious JFH-1 HCV RNA into Huh7 cells. However, this
experimental strategy would be less conclusive when addressing
later, post-replication events such as de novo HCVcc production
because the HCVcc ‘‘transfection-dependent’’ titers achieved at
early time points post-transfection are extremely low and only
become reliably detectable 48-72 h post-transfection after rounds of
‘‘entry-dependent’’ viral spread have occurred.
(iv) Permissiveness for HCVpp infection. While only the
Huh7-6 cell line showed reduced permissiveness for HCVcc, we
identified four cell lines (Huh7-4, -6, -7 and -8) that exhibited a
reduction in permissiveness for HCVpp. Although such a
reduction could easily explain the relatively non-permissive
phenotype of the Huh7-6 cells for HCVcc infection, none of the
other three cell lines showed impaired HCVcc infection kinetics,
particularly at early time points p.i. (Figure 5A and Figure S1).
This observation would suggest that the requirements for entry
may differ between the HCVpp and HCVcc systems.
Identifying cellular determinants of HCV permissiveness
To determine if the differences in HCVpp and HCVcc infection
could be attributed to factors already shown to modulate HCV
permissiveness in other Huh7 cell lines [4,6,19,20,24–27], we
examined the expression of HCV entry receptors (e.g. CD81,
LDL-R or SR-B1) and IFN responsiveness to dsRNA. Interest-
ingly, the data suggests that in this panel of Huh7 cells, CD81
expression levels more significantly influence HCVpp rather than
HCVcc permissiveness. Specifically, the Huh7-4 and -8 cell lines
exhibited a bimodal CD81 expression pattern (Figure S2A), which
significantly reduced their permissivity for HCVpp (Figure 6A).
This bimodal CD81 expression pattern is reminiscent of that
observed for the Huh7-Lunet cells [19]; however, although
bimodal CD81 levels restricted HCVcc infection in the Huh7-
Lunet cells, Huh7-4 and -8 cells were highly permissive for HCVcc
infection (Figure 5). The lack of reduced HCVcc infectivity
Table 1. Summary of Huh7 Cell Line Characteristics
a.
Cell Line CPE
b Average HCV Copies/mg RNA
d Average HCV Titers (FFU/ml)
e dsRNA Signaling
f JFH-1 Infectivity
g
Huh7-1 + (8)
c 3.04610
7 4.67610
4 ++++ ++++
Huh7-2 ++ (7) 2.68610
7 1.23610
5 +++ ++++
Huh7-3 ++++ (5) 2.94610
7 1.37610
5 ++++ ++++
Huh7-4 +++ (6) 2.53610
7 2.00610
4 ++++ ++++
Huh7-6 + (8) 2.82610
3 3.67610
1 +++ +
Huh7-7 ++++ (5) 2.35610
7 3.33610
4 ++++ ++++
Huh7-8 ++ (7) 1.39610
7 1.00610
4 +++ ++++
Huh7-9 ++++ (5) 4.08610
7 1.43610
5 ++ ++++
Huh7-RRB + (8) 1.68610
7 7.11610
4 n/d ++++
Huh7.5.1 ++++ (5) 2.44610
7 1.87610
5 n/d ++++
aRefer to Materials and Methods for definition of assays.
bCPE determined by microscopic examination. Changes in cell morphology, accumulation of floating cells and cessation of cell growth were scored basedo nt h e
percentage of cells in the infected culture exhibiting these characteristics: +++,h i g h( .80%); ++, medium (40–80%); + low (,40%); and undetectable.
cDay p.i. CPE was first evident.
dAverage intracellular HCV RNA (copies/mg RNA) for days 6–8 p.i. (Figure 5A).
eAverage infectivity titers (FFU/ml) for days 6–8 p.i. using respective Huh-7 cell line for assay (Figure 5B).
fAverage ISG expression following poly(IC) transfection: ++++, .10-fold; +++, 3–10-fold; ++, ,3-fold. (Figure 7B).
gHCV spread determined by indirect E2 immunofluorescence staining on day 7 p.i.: ++++, .90%; +++, 60–89; ++, 30–59%; +, ,30% E2-positive cells (Figure S1).
n/d=not determined.
doi:10.1371/journal.pone.0006561.t001
Figure 4. Phenotype of HCV-positive foci in different Huh7
lines during virus titration. Cells were overlaid with compete DMEM
containing methylcellulose to reduce secondary spread. At 72 h p.i. cells
were fixed and stained for HCV E2 [11] (magnification, 6100).
doi:10.1371/journal.pone.0006561.g004
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due to other differences between the cell lines or between the
HCV clone used by Koutsoudakis et al. (Jc1) versus this study
(JFH-1) [19]. As such, it would be interesting to determine the
permissiveness of Huh7-4 and Huh7-8 cells for Jc1-HCVcc to
ascertain if the critical surface density level of CD81 required for
entry varies among HCV clones [19]. Nonetheless, there does
appear to be a difference in dependency for CD81 between
HCVcc and HCVpp, which highlights an inherent difference
between these two model systems.
In terms of SR-B1 cell surface expression, only the Huh7-6 cell
line had undetectable levels of this critical HCV entry factor
(Figure S2C); however, complementation of Huh7-6 cells with
exogenous SR-B1 expression alone did not restore its permissive-
ness for HCVpp (Figure 6C) or HCVcc (data not shown) infection,
suggesting that although Huh7-6 cells lacked detectable cell
surface expression of SR-B1, this receptor alone was not the
limiting factor precluding HCVpp entry. Since claudin-1 [28] and
occludin [29,30] have also been shown to be necessary for HCVpp
and HCVcc entry, and since ectopic expression of these receptors
confers HCV permissiveness to non-permissive cells, we addition-
ally tested the ability of these receptors, alone or in combination
with SR-B1, to complement Huh7-6 cells, but none of the receptor
Figure 5. HCVcc replication kinetics. Cells were infected with JFH-1
HCVcc at an MOI of 0.01 FFU/cell. Culture supernatant and intracellular
RNA were collected at the indicated times p.i. (A) Intracellular HCV RNA
was analyzed by RTqPCR and is displayed as HCV copies/mg total RNA.
Results are graphed as mean6sem of triplicates. Infectivity titers,
expressed as FFU/ml, were determined on (B) the Huh7 cells from which
the virus was derived and (C) Huh7-1 cells.
doi:10.1371/journal.pone.0006561.g005
Figure 6. Huh7-6 cells are refractory for HCVpp infection. (A)
Huh7 cells lines, (B) Huh7-4 and Huh7-8 cells transiently transfected
with pEE6-huCD81, and (C) Huh7-6 cells transiently transfected with
expression plasmids expressing CD81, SR-B1, CLDN1, and/or occludin,
were infected with equal amounts of JFHpp, H77pp or VSVGpp. HCVpp
infectivity titers (relative light units (RLU)6sem for triplicate samples
determined 72 h p.i.), following background and mock-control signal
subtraction, were divided by the titer of VSVGpp and compared to the
signal in Huh7-1 cells.
doi:10.1371/journal.pone.0006561.g006
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(Figure 6C), suggesting that another yet unidentified HCV entry
factor may exist. As such, future studies to dissect and evaluate
why HCV entry into the Huh7-6 cells is limited seem warranted.
Since attenuation of the RIG-I/interferon regulatory factor 3
(IRF-3) pathway is believed to confer an advantage to HCVcc in
Huh7.5 and Huh7.5-derived cells [4,6,20], we tested whether
these eight Huh7 cell lines responded differently to dsRNA.
Although all cells responded well to IFN-b stimulation, obvious
differences in dsRNA responsiveness were apparent, with 3 out of
the 8 cell lines showing reduced responsiveness to poly(IC)
stimulation (Figure 7B), similar to that of Huh7.5.1 cells (data
not shown). Of interest, lower induction of IFN-induced genes in
response to dsRNA was observed in two of the most permissive cell
lines, Huh7-2 and Huh7-9 suggesting that defects in dsRNA
signaling may be contributing to the high HCV levels achieved in
these cells. However, attenuated responsiveness to dsRNA does
not necessarily limit HCVcc infection in specific cell lines because
the Huh7-3 cell line, which supported equally robust HCVcc
infection, showed high IFN stimulated gene induction in response
to dsRNA. Such seeming discordances are in agreement with a
recent study by Binder et al showing no correlation between HCV
permissiveness and inducibility of the RIG-I/IRF-3 pathway in
several Huh7 cell lines and cured replicon clones [21]. Taken
together, it appears as though the absence of a functional RIG-I/
interferon regulatory factor 3 (IRF-3) pathway may not be critical
for HCV replication as previously hypothesized.
Identifying cellular determinants of HCV-mediated
cytopathic effect
HCV has long been regarded as a non-cytopathic virus;
however, the observation that HCVcc can induce CPE in Huh7
cells suggests that at sufficient levels HCV can be deleterious to the
cell [6]. During propagation of HCVcc, we noted varying degrees
of CPE in the different Huh7 cell lines (Figure 3C), which did not
simply correlate with the level of HCV replication. For example,
the Huh7-2 cell propagated HCV to similar levels as the Huh7-3
cells, but only the Huh7-3 cells exhibited high HCV-induced CPE.
With recent studies indicating that HCV can directly induce
apoptosis of infected cells via a Bax-triggered, mitochondrion-
mediated, caspase 3-dependent pathway and/or a TRAIL-
induced caspase 9-dependent manner [31,32], identifying differ-
ential activity of these and/or other cellular pathways in the
different Huh7 cell lines may help better dissect the mechanisms
responsible for HCV-mediated CPE.
In summary, these data provide us with a characterized panel of
HCVcc permissive and non-permissive Huh7 cells. While this study
confirms that changes in HCV entry factors represent a common
reason for reduced permissiveness to HCVpp and HCVcc infection
and that reduced responsiveness to dsRNA can be associated with
higher HCVcc infection levels, these cell lines display differences in
infectious HCVcc production independent of these previously
identified cellular determinants and hence should prove useful for
elucidating other critical Huh7 cell factors involved in HCV
infection and HCV-mediated cytotoxicity. Importantly, the differ-
ences observed among theseindependently acquired Huh7 cell lines
also highlights that in some cases, phenotypic differences between
Huh7 cells may need to be considered when comparing HCV
studies across laboratories. Although these differences raise
questions regarding whether the commercially available original
Huh7 cells (Huh7-RRB) should be adopted as some type of
‘‘standard’’ in the field, the comparison of HCVcc infection
dynamics in multiple Huh7 cell lines also clearly can provide
insight into the viral-host interactions required for infection.
Figure 7. ISG induction in Huh7 lines. (A) EGFP expression in each Huh7 cell line 16 h post-transfection with 100 ng pEGFP-N1. EGFP protein
visualized by Axiovert 200 fluorescence microscope. EGFP mRNA determined by RTqPCR (bottom). (B) In parallel, additional wells were mock-treated
(grey bars), transfected with 300 ng poly(I/C) (black bars) or treated with 100 U/ml IFN-b (white bars). Cellular RNA was harvested 16 h post treatment
and ISG expression was assessed by RTqPCR. Values are expressed as mean fold-induction6sem for triplicate samples compared to untreated controls.
doi:10.1371/journal.pone.0006561.g007
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Supplementary Materials and Methods S1
Found at: doi:10.1371/journal.pone.0006561.s001 (0.07 MB
DOC)
Table S1 Primer Sequences for RTqPCR
Found at: doi:10.1371/journal.pone.0006561.s002 (0.02 MB
PDF)
Figure S1 Kinetics of HCV spread and protein expression in
Huh7 cell lines. Indirect immunofluorescence analysis of HCV E2
protein expression in Huh7 cells infected at an MOI of 0.01 FFU/
cell and cultured for 7 days p.i. HCV E2 is red (Alexa 555) and
nuclei are blue (Hoechst). Magnification6100.
Found at: doi:10.1371/journal.pone.0006561.s003 (16.25 MB
TIF)
Figure S2 Subgenomic HCV G418-resistant colony formation
in Huh7 cell lines. One mg of in vitro transcribed sg JFH-1 RNA
was electroporated into 2610
6 cells of each Huh7 cell line. Cells
were diluted 1:500 and plated in 6-well plates, in triplicate, and
maintained in the presence of 500 mg/ml G418 for 2 weeks.
Colonies were fixed, stained with crystal violet and photographed.
Found at: doi:10.1371/journal.pone.0006561.s004 (1.06 MB
PDF)
Figure S3 Flow cytometric analysis of HCV putative receptor
surface expression on Huh7 cell lines. Each Huh7 cell line was
stained with (A) mouse anti-CD81, (B) mouse anti-LDL-R or (C)
rabbit anti-SR-B1 monoclonal antibodies and respective anti-
mouse or anti-rabbit secondary antibodies conjugated with PE.
Shaded regions represent cells stained with a monoclonal mouse or
rabbit IgG control primary antibody and respective PE-conjugated
secondary antibody.
Found at: doi:10.1371/journal.pone.0006561.s005 (2.14 MB TIF)
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